Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock
VHAQ.U
VHAQ.U was delisted on the 21st of February, 2024.
4 hedge funds and large institutions have $1.24M invested in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
5% less capital invested
Capital invested by funds: $1.31M → $1.24M (-$69K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$9.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$108K |
| 2 |
Morgan Stanley
New York
|
-$13.8K |
VHAQ.U Hedge Fund Activity: Q2 2022 in Review
4 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) for Q2 2022, worth a combined $1.24M — down 5.3% from $1.31M a quarter earlier.
Fund positioning in VHAQ.U was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Clear Street, opening a new position worth an estimated $9.73K. The largest seller was Citadel Advisors, exiting entirely with an estimated $108K sold.
- 4 institutional investors held Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock (VHAQ.U) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $1.24M of Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock stock for Q2 2022, down 5.3% quarter-over-quarter.
- 1 fund opened new Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock buyer in Q2 2022 was Clear Street, an estimated $9.73K added.
- The largest Viveon Health Acquisition Corp. Units, each consisting of one share of common stock, one Warrant entitling the holder to purchase one-half of a share of common stock, and one right to receive one-twentieth of a share of common stock seller in Q2 2022 was Citadel Advisors, an estimated $108K sold.
Based on aggregated 13F filings for Q2 2022.